You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Harvard Business School
Boehringer Ingelheim
Dow
AstraZeneca

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Protein-bound paclitaxel

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Protein-bound paclitaxel?

Protein-bound paclitaxel is an investigational drug.

There have been 169 clinical trials for Protein-bound paclitaxel. The most recent clinical trial was a Phase 3 trial, which was initiated on December 1st 2019.

The most common disease conditions in clinical trials are Breast Neoplasms, Adenocarcinoma, and Carcinoma. The leading clinical trial sponsors are National Cancer Institute (NCI), M.D. Anderson Cancer Center, and Celgene Corporation.

Recent Clinical Trials for Protein-bound paclitaxel
TitleSponsorPhase
Study of Sacituzumab Govitecan (IMMU-132) in Metastatic or Locally Advanced Unresectable Urothelial CancerImmunomedics, Inc.Phase 3
New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc StudyNational Cancer Institute (NCI)Phase 2
New and Emerging Therapies for the Treatment of Resectable, Borderline Resectable, or Locally Advanced Pancreatic Cancer, PIONEER-Panc StudyM.D. Anderson Cancer CenterPhase 2

See all Protein-bound paclitaxel clinical trials

Clinical Trial Summary for Protein-bound paclitaxel

Top disease conditions for Protein-bound paclitaxel
Top clinical trial sponsors for Protein-bound paclitaxel

See all Protein-bound paclitaxel clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
McKinsey
Harvard Business School
Boehringer Ingelheim
Dow
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.